Literature DB >> 9668591

A trial to investigate the relationship between DFO pharmacokinetics and metabolism and DFO-related toxicity.

J B Porter1, A Faherty, L Stallibrass, L Brookman, I Hassan, C Howes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668591     DOI： 10.1111/j.1749-6632.1998.tb10528.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

Authors:  Zhi Liu; Jing Qiao; Tamas Nagy; May P Xiong
Journal:  J Control Release       Date:  2018-05-22       Impact factor: 9.776

2.  Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.

Authors:  Zhi Liu; Tien-Min Lin; Max Purro; May P Xiong
Journal:  ACS Appl Mater Interfaces       Date:  2016-09-26       Impact factor: 9.229

3.  Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo.

Authors:  Yan Wang; Zhi Liu; Tien-Min Lin; Shaurya Chanana; May P Xiong
Journal:  Int J Pharm       Date:  2018-01-16       Impact factor: 5.875

4.  Polymeric nanocarriers for the treatment of systemic iron overload.

Authors:  Jasmine L Hamilton; Jayachandran N Kizhakkedathu
Journal:  Mol Cell Ther       Date:  2015-03-24

5.  Mechanic-Driven Biodegradable Polyglycolic Acid/Silk Fibroin Nanofibrous Scaffolds Containing Deferoxamine Accelerate Diabetic Wound Healing.

Authors:  Shenfang Zha; Yohanes Kristo Sugiarto Utomo; Li Yang; Guizhao Liang; Wanqian Liu
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.